Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07258485 · ClinicalTrials.gov registry record

A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)

A clinical trial of Depressive Disorder, Major, sponsored by Janssen Research & Development.

Recruiting
Registry status
80
Enrollment target
14
Study locations

NCT07258485 is a study of Depressive Disorder, Major that is actively recruiting participants, run by Janssen Research & Development. The registered enrollment target is 80 participants, below the 241-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (67% lower). The trial reports 14 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07258485, a study of Depressive Disorder, Major, is actively recruiting participants, sponsored by Janssen Research & Development.

RECRUITING
Registry status
80 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this study is to evaluate sleep in participants with Major Depressive Disorder with moderate to severe insomnia symptoms (MDDIS) or MDD with no or mild insomnia symptoms (non-MDDIS), using an at-home sleep Electroencephalogram (EEG; a device that records brain activity during sleep). The study also aims to examine the association between objective sleep EEG features (measured using devices) and subjective sleep measures (self-reported experiences, such as how a person feels about their sleep) in participants with MDDIS or non-MDDIS.

Conditions Studied

Depressive Disorder, Major

Study Locations (14)

California

  • Behavioral Research Specialists LLC - Glendale
  • Pacific Clinical Research Medical Group - Upland
  • Sunwise Clinical Research - Walnut Creek

Florida

  • Velocity Clinical Research - Hallandale
  • Meridian International Research - Miami Gardens

Massachusetts

  • Adams Clinical - Boston
  • Adams Clinical - Watertown

New York

  • Adams Clinical - New York
  • Adams Clinical - The Bronx

Illinois

  • IMA Clinical Research PC - Chicago

Pennsylvania

  • Adams Clinical - Philadelphia

Texas

  • Adams Clinical - DeSoto

Utah

  • Inner Space Research LLC - Orem

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-11-24
Est. Completion 2026-04-24

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07258485

The ClinicalTrials.gov registry entry for NCT07258485 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (67% lower). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depressive Disorder, Major appearing as the primary indexed condition, and to 0 interventions.

NCT07258485 reports 14 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07258485 about?

NCT07258485 is a clinical study titled "A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)". The purpose of this study is to evaluate sleep in participants with Major Depressive Disorder with moderate to severe insomnia symptoms (MDDIS) or MDD with no or mild insomnia symptoms (non-MDDIS), using an at-home sleep Electroencephalogram (EEG; a device that records brain activity during sleep). ...

What is the current status of trial NCT07258485?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-11-24. Estimated completion is 2026-04-24.

What conditions does trial NCT07258485 study?

This clinical trial studies the following conditions: Depressive Disorder, Major.

Who is sponsoring clinical trial NCT07258485?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07258485 being conducted?

This trial has 14 study locations across California, Florida, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depressive Disorder, Major

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depressive Disorder, Major

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.